Get the app!
Back to Trades
Grant4

Anika Therapeutics, Inc.

ANIK

Total Value
$31.7K

Company Information

Ticker Symbol
ANIK
CIK
0000898437

Insider Information

Role
Insider
Location
BEDFORD, MA

Filing Details

Filing Date
Mar 17, 2026
Transaction Date
Mar 14, 2026
Accession Number
0001193125-26-111492
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Mar 14, 2026Common Stock3,774Exercise
Mar 14, 2026Common Stock1,161Grant/Award
Mar 14, 2026Common Stock1,449$14.20Tax Withholding$20.6K
Mar 15, 2026Common Stock2,658Exercise
Mar 15, 2026Common Stock781$14.20Tax Withholding$11.1K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Mar 14, 2026Derivative3,774Exercise
Mar 15, 2026Derivative2,658Exercise

Footnotes

  1. (F1)Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
  2. (F2)On March 14, 2025, the Reporting Person was granted 3,484 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
  3. (F3)Reflects an aggregate of 1,449 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
  4. (F4)Reflects an aggregate of 781 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.
  5. (F5)On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.
  6. (F6)On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.